Sign in

    Ashley Helen

    Senior Analyst at Jefferies

    Ashley Helen is a Senior Analyst at Jefferies specializing in equity research within the healthcare sector, with a particular focus on covering major pharmaceutical and biotechnology companies. She is recognized for her strong performance record, consistently achieving high success rates on platforms such as TipRanks and generating above-market returns with her investment recommendations. Ashley began her analyst career in the early 2010s, having previously held roles at top investment banks before joining Jefferies in 2018. She holds Series 7 and Series 63 licenses and is FINRA-registered, with notable achievements including recognition in industry-wide analyst rankings.

    Ashley Helen's questions to Sally Beauty Holdings (SBH) leadership

    Ashley Helen's questions to Sally Beauty Holdings (SBH) leadership • Q4 2024

    Question

    On behalf of Ashley Helen, Sidney Vranesh asked for more detail on the key takeaways from the 'Studio by Sally' initiative that are being incorporated into the new brand refresh.

    Answer

    President and CEO Denise Paulonis detailed that key learnings from 'Studio by Sally' include store format changes like lower fixtures for better sightlines, reduced SKU counts to add more educational content, and an improved nail category layout. She also explained that learnings from the in-store service component were evolved and scaled into the successful 'Licensed Colorist OnDemand' digital platform, which offers online professional consultations.

    Ask Fintool Equity Research AI